Skip to main content

Advertisement

Log in

Evaluation of the Protection Provided by Hepatitis B Vaccination in India

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

In India, Hepatitis B vaccination is recommended at 6 wk except for hospital-deliveries. The authors examined protection afforded by the birth dose.

Methods

A case-control study was done. HBsAg and HBcAb were tested in 2671 children, 1 to 5 y and HBsAb was evaluated in a subset of 1413 children. Vaccination history was recorded. Cases were HBsAg carriers. In another analysis, children who got infected (HBsAg and/or HBcAb positive) were considered as cases. Exposed were the unvaccinated. In another analysis, exposed were those vaccinated without the birth dose.

Results

The odds ratio (OR) for HBsAg positivity with birth vaccination was 0.35 (95% CI 0.19–0.66); while with vaccination at 6 wk was 0.29 (95%CI 0.14–0.61), both compared to unvaccinated. Birth vaccination has no added protection when compared to the unvaccinated. Unvaccinated children in index study had HBsAg positivity of 4.38%. The number needed to treat (NNT) to prevent one case of HBsAg positivity was 32.6 (95% CI, 20.9 to 73.6). The odds of getting HBV infection was 0.42 (CI 0.25–0.68) with birth dose and 0.49 (CI 0.30–0.82) without the birth dose compared to the unvaccinated. Protective antibody (HBsAb) was present in about 70% of the vaccinated. In the unimmunised, in the first 2 y HBsAb protection was present in 40%. The odds ratio (OR) for HBsAb in the fully vaccinated between 4 and 5 y was 1.4 (95%CI 0.9–2.18) compared to the unvaccinated.

Conclusions

The present study lends support to the pragmatic approach of the Government to vaccinate babies born at home starting at 6 wk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007;44:663–74.

    PubMed  Google Scholar 

  2. Puliyel JM. Policy analysis of the use of hepatitis B, Hemophilius influenzae type B, Steptococcus pneumoniae-conjugate and rotavirus vaccines in the national immunization schedules. Health Econ. 2004;13:1147.

    Article  PubMed  Google Scholar 

  3. Dhir V, Mohandas KM. Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. Indian J Gastroenterol. 1999;18:24–8.

    PubMed  CAS  Google Scholar 

  4. Jensen MK, Balistreri WF. Viral hepatitis. In: Kliegman RM, Stanton B, Geme JS, Schor NF, Behrman RE, editors. Nelson Textbook of Pediatrics, 20th ed. New Delhi: Elsevier Science Health Science; 2015.

  5. Shah U, Kelly D, Chang MH, et al. Management of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr. 2009;48:399–404.

    Article  PubMed  Google Scholar 

  6. Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987;21:137–45.

    Article  PubMed  CAS  Google Scholar 

  7. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006;2:CD004790.

    Google Scholar 

  8. Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol. 1994;140:734–46.

    Article  PubMed  CAS  Google Scholar 

  9. Ministry of Health and Family Welfare I. Immunizatio_UIP. wwwmohfwnicin [Internet]. Available at: http://www.mohfw.nic.in/WriteReadData/l892s/Immunization_UIP.pdf. Accessed on 5th May 2017.

  10. Puliyel JM, Rastogi P, Mathew JL. Hepatitis B in India: systematic review & report of the 'IMA sub-committee on immunization'. Indian J Med Res. 2008;127:494–7.

    PubMed  Google Scholar 

  11. Geeta MG, Riyaz A. Prevention of mother to child transmission of hepatitis B infection. Indian Pediatr. 2013;50:189–92.

    Article  PubMed  CAS  Google Scholar 

  12. Gupta I, Sehgal A, Sehgal R, Ganguly NK. Vertical transmission of hepatitis B in north India. J Hygiene, Epidemiol Microbiol Immunol. 1992;36:263–7.

  13. Puri P. Tackling the hepatitis B disease burden in India. J Clin Exp Hepatol. 2014;4:312–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Abass F, Thomas RD, Rajkumar A, Gupta N, Puliyel JM. Controlling perinatally acquired hepatitis B. Indian J Pediatr. 2001;68:365.

    Article  PubMed  CAS  Google Scholar 

  15. Aggarwal R, Babu JJ, Hemalatha R, Reddy AV, Sharma D, Kumar T. Effect of inclusion of hepatitis B vaccine in childhood immunization program in India: a retrospective cohort study. Indian Pediatr. 2014;51:875–9.

    Article  PubMed  Google Scholar 

  16. Indian Association for Study of the Liver (INASL). Hepatitis B in India; therapeutic options and prevention strategies – Consensus statement. Indian J Gastroenterol. 2000;19:C54–66.

  17. Borkakoty B, Mahanta J, Biswas D. HBV vaccination in hyperendemic remote tribal areas in India. Vaccine. 2007;25:8347–9.

    Article  PubMed  Google Scholar 

  18. Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: implications for blood transfusion. Indian J Med Res. 2010;132:312–7.

    PubMed  Google Scholar 

  19. Waaijenborg S, Hahne SJ, Mollema L, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208:10–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

This multicenter study was conceived by JP and designed originally by JP, PN, AP KA and VS. AP developed the computer architecture for data monitoring and VS helped with the statistical analysis. PN was responsible for study in Surat; DN, VT, PT, JP were responsible for study in Delhi centres; SKS and US for UP; RS for Uttarakhand. VL and NK were responsible for testing and interpretation of the test data.

The first draft was written by PN and it was finalised with critical inputs from each of the authors. AP was responsible for the write up on the computer programme used and he overlooks the data availability and will ensure it is available openly with no conditions attached.

Each author has seen the final draft, takes responsibility for its contents and signed the copyright transfer forms. JP will be the guarantor for the study report.

Corresponding author

Correspondence to Jacob Puliyel.

Ethics declarations

Conflict of Interest

None.

Source of Funding

Indian Council of Medical Research, Delhi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Puliyel, J., Naik, P., Puliyel, A. et al. Evaluation of the Protection Provided by Hepatitis B Vaccination in India. Indian J Pediatr 85, 510–516 (2018). https://doi.org/10.1007/s12098-017-2601-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-017-2601-0

Keywords

Navigation